Business Context and Reporting Period
Company: MaxCyte, Inc. (MXCT)
Filing Type: Form 8-K (Current Report)
Date of Report: August 12, 2026
Reporting Period: Quarter ended June 30, 2026
Context: The filing announces the release of financial results for the second quarter of 2026 and the posting of an updated corporate presentation.
Key Financial Metrics
The provided text is a cover sheet for the Form 8-K and does not contain specific financial data. It references a press release (Exhibit 99.1) and a corporate presentation (Exhibit 99.2) where the actual figures are located. Consequently, the following metrics are not available in the source text:
- Revenue
- Profit/Loss
- Cash Flow
- Margins
- Debt and Liquidity
Note: The filing text does not provide a clear value for any financial metric.
Material Changes
No material changes regarding financial performance or operations are detailed in the provided text. The filing serves solely to notify investors of the availability of the Q2 2026 results and updated corporate materials.
Guidance, Outlook, and Risks
Guidance and Outlook: The filing mentions an updated corporate presentation was posted to the company website, which may contain forward-looking information, but the text itself does not summarize specific guidance or outlook figures.
Risks and Contingencies: No specific risks or contingencies are described in the provided text.
Unusual Items: None reported in the text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q2 2026 revenue, net loss, and cash position figures.
- Access the updated corporate presentation (Exhibit 99.2) on the investor relations website for management commentary and future outlook.
- Verify the company's status as an Emerging Growth Company (indicated as checked in the filing) and its implications for financial reporting standards.
- Confirm the date of the financial results announcement (August 12, 2026) against market data.